Literature DB >> 7221359

Kinetics of antimicrobial action.

H Mattie.   

Abstract

To better quantify the relative antibacterial activity of beta-lactam antibiotics in vitro, mathematical descriptions of bacterial growth were developed. Growth curves for the initial 2-to 4-hr period of exposure to antibiotic can be expressed as quadratic functions of time. Moreover, the rate of change of growth (a) shows a linear dependence on the logarithm of the antibiotic concentration. For some drug-organism interactions, the initial growth rate (k0) is also a concentration-dependent variable. This mathematical quantitation of the antibacterial action of a drug in vitro covers a range of concentrations above and below its minimal inhibitory concentration. The slope of the regression line of a on log concentration may vary for different microorganisms and antibiotics. However, several analogues yield parallel concentration-effect slopes, a circumstance allowing for the calculation of potency ratios. Two murine models were used to determine if these in vitro studies could predict activity in vivo. The relative efficacy in vivo also was expressed as a potency ratio, which was measured in terms of the number of bacteria in either homogenized kidney after intravenous challenge or an infected thigh muscle. For drugs with similar pharmacokinetics, the potency in vivo could be predicted from the value in vitro. However, for drugs with concentration curves in serum of different shapes, the potency in vivo varied from the value in vitro. A more prolonged course of drug in serum, which yielded a flatter concentration curve, appeared to be associated with greater activity in vivo.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7221359     DOI: 10.1093/clinids/3.1.19

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  14 in total

Review 1.  Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC.

Authors:  Markus Mueller; Amparo de la Peña; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

2.  Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in an experimental infection.

Authors:  W E Peetermans; J J Hoogeterp; A M Hazekamp-van Dokkum; P van den Broek; H Mattie
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

3.  Effect of clavulanic acid and/or polymorphonuclear neutrophils on amoxicillin bactericidal activity against Streptococcus pneumoniae.

Authors:  M Martín; M L Gómez-Lus; L Aguilar; P Martínez; M J Giménez; J Prieto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-07       Impact factor: 3.267

4.  Activities against Streptococcus pneumoniae of amoxicillin and cefotaxime at physiological concentrations: in vitro pharmacodynamic simulation.

Authors:  I P Balcabao; L Aguilar; M Martín; Y García; R Dal-Ré; J Prieto
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

5.  Seven hours to adequate antimicrobial therapy in urosepsis using isothermal microcalorimetry.

Authors:  Olivier Braissant; Georg Müller; Adrian Egli; Andreas Widmer; Reno Frei; Armin Halla; Dieter Wirz; Thomas C Gasser; Alexander Bachmann; Florian Wagenlehner; Gernot Bonkat
Journal:  J Clin Microbiol       Date:  2013-11-13       Impact factor: 5.948

6.  Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections.

Authors:  Peter Ankomah; Bruce R Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

7.  Postantibiotic and bactericidal effect of imipenem against Pseudomonas aeruginosa.

Authors:  I Odenholt; B Isaksson; L Nilsson; O Cars
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-02       Impact factor: 3.267

8.  Microbial pharmacodynamics of piperacillin in neutropenic mice of systematic infection due to Pseudomonas aeruginosa.

Authors:  J G Zhi; C H Nightingale; R Quintiliani
Journal:  J Pharmacokinet Biopharm       Date:  1988-08

9.  Concentration-effect relationship of ceftazidime explains why the time above the MIC is 40 percent for a static effect in vivo.

Authors:  Johan W Mouton; Nieko Punt; Alexander A Vinks
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

10.  Quantitative effect of granulocytes on antibiotic treatment of experimental staphylococcal infection.

Authors:  J J Hoogeterp; H Mattie; A M Krul; R van Furth
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.